Anna M. Frable has been Vice President, Communications for Novo
Nordisk Inc. since April 2016 and joined the Executive Team in
February 2020. She leads the Communications function and is
responsible for the strategic oversight of communications and public
relations efforts that advance the company’s business priorities and
reputation in the US as well as understanding of its purpose.
Ms. Frable has more than 25 years of healthcare communications
and industry experience. Prior to joining Novo Nordisk, Inc., Ms.
Frable spent nearly 20 years at Novartis in various leadership
positions including Vice President of Communications & US
Country Head of Communications. In this role, she was responsible
for promoting and protecting the company brand and reputation as
well as leading communications for significant initiatives across
the different Novartis divisions in the US. She also led strategic
communications for the General Medicines business at Novartis
Pharmaceuticals Corporation (NPC). She served on the NPC General
Medicines Executive Committee as well as the Novartis US Pharma,
Compliance and Country Executive Committees.
Earlier roles at Novartis included a secondment in the company’s
global headquarters in Switzerland to optimize the global
pharmaceuticals communications function. She also served as Vice
President, Corporate Communications for CIBA Vision Worldwide (now a
part of Alcon, a Novartis company).
Prior to Ms. Frable’s corporate communication positions at Novo
Nordisk and Novartis, she held senior leadership positions at global
public relations firms primarily focused on the healthcare and
In 2012, Ms. Frable was named among the Healthcare Businesswomen
Association’s Rising Stars.
Ms. Frable received a Bachelor of Arts in Communication from the
University of Miami.